Partneringreview 2006 - Therapy area (volume 2)

Partneringreview 2006 - Therapy area (volume 2) published by Pharmalicensing Ltd. in February, 2006. This report consists of 1802 pages and the price starts from US $ 2495.

Introduction

Abstract

Partneringreview 2006 -- Volume 2: Therapy area provides an in depth view into the deals and alliances by therapeutic area announced in 2005, in a clear and accessible format. The report reviews over 2,600 deal announcements in therapeutic areas - oncology, infectious disease, cardiovascular, circulatory, central nervous system, autoimmune, inflammation, metabolism, respiratory, gastrointestinal, musculoskeletal, sensory organ, oral health, genitourinary, gynecology, dermatology, blood system, lymphatic system, and accident/hospital/trauma.

Each sector is further divided to analyze deals by company, industry sector, and stage of development. Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront and milestone payments, where disclosed. Each deal is annotated with a deal number, such as #43. This number links to the full deal in the deal listing at the rear of each report. When using the PDF format in Acrobat Reader, simply click on the number to move around the report.

All the year's deals at a glance.

Want to know what your competitors are doing? Want to benchmark your deals against others in your therapeutic area or see how the finances of different deal types compare? Partneringreview 2006 brings all the 2005's deals into focus in one place.

Partneringreview is a comprehensive summary of the year's deal announcements in a clear and accessible printable format. Every deal entry includes financial information where disclosed, such as headline values and upfront and milestone payments. A new addition of an overview of financings from investors is also included in this latest edition.

Partneringreview 2006 is the full report of all the deals data collected in 2005, providing a broad perspective of deal announcements, and incorporates all six volumes.

Table of Contents

INTRODUCTION

• About Partneringreview
• Full contents of Partneringreview 2006
• Review of deal making in 2005
• Deals announced by therapy area

VOLUME 2: THERAPY AREA

Chapter 1: Oncology

• Deals in the oncology therapy area by company
• Deals in the oncology therapy area by industry focus
• Deals in the oncology therapy area by development stage

Chapter 2: Infectious disease

• Deals in the infectious disease therapy area by company
• Deals in the infectious disease therapy area by industry focus
• Deals in the infectious disease therapy area by development stage

Chapter 3: Cardiovascular/Circulatory

• Deals in the cardiovascular/circulatory therapy area by company
• Deals in the cardiovascular/circulatory therapy area by industry focus
• Deals in the cardiovascular/circulatory therapy area by development stage

Chapter 4: Central Nervous System

• Deals in the central nervous system therapy area by company
• Deals in the central nervous system therapy area by industry focus
• Deals in the central nervous system therapy area by development stage

Chapter 5: Autoimmune/Inflammation

• Deals in the autoimmune/inflammation therapy area by company
• Deals in the autoimmune/inflammation therapy area by industry focus
• Deals in the autoimmune/inflammation therapy area by development stage

Chapter 6: Metabolism

• Deals in the metabolism therapy area by company
• Deals in the metabolism therapy area by industry focus
• Deals in the metabolism therapy area by development stage

Chapter 7: Respiratory

• Deals in the respiratory therapy area by company
• Deals in the respiratory therapy area by industry focus
• Deals in the respiratory therapy area by development stage

Chapter 8: Gastrointestinal

• Deals in the gastrointestinal therapy area by company
• Deals in the gastrointestinal therapy area by industry focus
• Deals in the gastrointestinal therapy area by development stage

Chapter 9: Musculoskeletal

• Deals in the musculoskeletal therapy area by company
• Deals in the musculoskeletal therapy area by industry focus
• Deals in the musculoskeletal therapy area by development stage

Chapter 10: Sensory Organ/Oral Health

• Deals in the sensory organ/oral health therapy area by company
• Deals in the sensory organ/oral health therapy area by industry focus
• Deals in the sensory organ/oral health therapy area by development stage

Chapter 11: Genitourinary/Gynecology

• Deals in the genitourinary/gynecology therapy area by company
• Deals in the genitourinary/gynecology therapy area by industry focus
• Deals in the genitourinary/gynecology therapy area by development stage

Chapter 12: Dermatology

• Deals in the dermatology therapy area by company
• Deals in the dermatology therapy area by industry focus
• Deals in the dermatology therapy area by development stage

Chapter 13: Blood/Lymphatic System

• Deals in the blood/lymphatic system therapy area by company
• Deals in the blood/lymphatic system therapy area by industry focus
• Deals in the blood/lymphatic system therapy area by development stage

Chapter 14: Accident/Hospital/Trauma

• Deals in the accident/hospital/trauma therapy area by company
• Deals in the accident/hospital/trauma therapy area by industry focus
• Deals in the accident/hospital/trauma therapy area by development stage

Chapter 15: List of deals

Tables

• Table 1 Top oncology area dealmaking companies in 2005
• Table 2 Top infectious disease area dealmaking companies in 2005
• Table 3 Top cardiovascular/circulatory area dealmaking companies in 2005
• Table 4 Top central nervous system area dealmaking companies in 2005
• Table 5 Top autoimmune/inflammation area dealmaking companies in 2005
• Table 6 Top metabolism area dealmaking companies in 2005
• Table 7 Top respiratory area dealmaking companies in 2005
• Table 8 Top gastrointestinal area dealmaking companies in 2005
• Table 9 Top musculoskeletal area dealmaking companies in 2005
• Table 10 Top sensory organ/oral health area dealmaking companies in 2005
• Table 11 Top genitourinary/gynecology area dealmaking companies in 2005
• Table 12 Top dermatology area dealmaking companies in 2005
• Table 13 Top blood/lymphatic system area dealmaking companies in 2005
• Table 14 Top accident/hospital/trauma area dealmaking companies in 2005

Figures

• Fig. i.1 Deals announced by therapy focus
• Fig. 1.1 Announcements in the oncology therapy area by company
• Fig. 1.2 Announcements in the oncology therapy area by industry sector
• Fig. 1.3 Announcements in the oncology therapy area by development stage
• Fig. 2.1 Announcements in the infectious disease therapy area by company
• Fig. 2.2 Announcements in the infectious disease therapy area by industry sector
• Fig. 2.3 Announcements in the infectious disease therapy area by development stage
• Fig. 3.1 Announcements in the cardiovascular/circulatory therapy area by company
• Fig. 3.2 Announcements in the cardiovascular/circulatory therapy area by industry sector
• Fig. 3.3 Announcements in the cardiovascular/circulatory therapy area by development
• Fig. 4.1 Announcements in the central nervous system therapy area by company
• Fig. 4.2 Announcements in the central nervous system therapy area by industry sector
• Fig. 4.3 Announcements in the central nervous system therapy area by development stage
• Fig. 5.1 Announcements in the autoimmune/inflammation therapy area by company
• Fig. 5.2 Announcements in the autoimmune/inflammation therapy area by industry sector
• Fig. 5.3 Announcements in the autoimmune/inflammation therapy area by development stage
• Fig. 6.1 Announcements in the metabolism therapy area by company
• Fig. 6.2 Announcements in the metabolism therapy area by industry sector
• Fig. 6.3 Announcements in the metabolism therapy area by development stage
• Fig. 7.1 Announcements in the respiratory therapy area by company
• Fig. 7.2 Announcements in the respiratory therapy area by industry sector
• Fig. 7.3 Announcements in the respiratory therapy area by development stage
• Fig. 8.1 Announcements in the gastrointestinal therapy area by company
• Fig. 8.2 Announcements in the gastrointestinal therapy area by industry sector
• Fig. 8.3 Announcements in the gastrointestinal therapy area by development stage
• Fig. 9.1 Announcements in the musculoskeletal therapy area by company
• Fig. 9.2 Announcements in the musculoskeletal therapy area by industry sector
• Fig. 9.3 Announcements in the musculoskeletal therapy area by development stage
• Fig. 10.1 Announcements in the sensory organ/oral health therapy area by company
• Fig. 10.2 Announcements in the sensory organ/oral health therapy area by industry sector
• Fig. 10.3 Announcements in the sensory organ/oral health therapy area by development
• Fig. 11.1 Announcements in the genitourinary/gynecology therapy area by company
• Fig. 11.2 Announcements in the genitourinary/gynecology therapy area by industry sector
• Fig. 11.3 Announcements in the genitourinary/gynecology therapy area by development
• Fig. 12.1 Announcements in the dermatology therapy area by company
• Fig. 12.2 Announcements in the dermatology therapy area by industry sector
• Fig. 12.3 Announcements in the dermatology therapy area by development stage
• Fig. 13.1 Announcements in the blood/lymphatic system therapy area by company
• Fig. 13.2 Announcements in the blood/lymphatic system therapy area by industry sector
• Fig. 13.3 Announcements in the blood/lymphatic system therapy area by development stage
• Fig. 14.1 Announcements in the accident/hospital/trauma therapy area by company
• Fig. 14.2 Announcements in the accident/hospital/trauma therapy area by industry sector
• Fig. 14.3 Announcements in the accident/hospital/trauma therapy area by development

Related Reports